COMMUNIQUÉS West-GlobeNewswire

Konica Minolta Healthcare Announces the UGPro Solution, a New Initiative Providing Complete Solutions for Ultrasound Guided Procedures
07/08/2018
WAYNE, N.J., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Konica Minolta Healthcare Americas, Inc., a leader in MSK Ultrasound, announces UGPro™ Solution, a new initiative that provides complete solutions for ultrasound guided [...]
BIONOVELUS CORRECTS RELEASE DATED AUGUST 3, 2018 AND HAS NOT ENTERED INTO ANY SETTLEMENT AGREEMENT WITH L2 CAPITAL
07/08/2018
FOR IMMEDIATE CORRECTIVE RELEASE — Phoenix, Aug. 07, 2018 (GLOBE NEWSWIRE) -- — As previously announced, BioNovelus (ONOV) (the “ Company ”) did enter into a Claim Purchase Agreement on June 30, 2018 with L2 Capital, [...]
Obalon Announces Upcoming Conference Presentation
07/08/2018
SAN DIEGO, Aug. 07, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric balloon [...]
ContraVir Pharmaceuticals Completes Data Analysis of Second Cohort in Part 1 of the Phase 1/2a Study of CRV431
07/08/2018
EDISON, N.J., Aug. 07, 2018 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), a biopharmaceutical company focused on the development and commercialization of therapeutic drugs for the treatment of [...]
Aptevo Therapeutics Revises Term Loan Agreement With MidCap Financial; Reduces Cash Requirements by $18 Million
07/08/2018
Defers Principal Repayments to February 2020 and Reduces Restricted Cash Covenant Aptevo to Announce Second Quarter 2018 Financial Results on August 9, 2018 SEATTLE, Aug. 07, 2018 (GLOBE NEWSWIRE) -- Aptevo Therapeutics [...]
Align Technology and DentalXP Launch Global Orthodontic Aligner Fellowship Program to Help Integrate Invisalign Treatment Into Practices
07/08/2018
Online Certification Program Endorsed by New York University (NYU) College of Dentistry, Provides Modular Training for Align’s End-to-End Digital Workflow Including iTero Scanning Technology SAN JOSE, Calif., Aug. 07, [...]
REVA Medical Reports Second Quarter 2018 Financial Results
07/08/2018
SAN DIEGO, Aug. 07, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX: RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular medical applications, today provided a business update [...]
Emerald Health Expands into Analytical Testing and Import/Export -- CFN Media
07/08/2018
SEATTLE, WA, Aug. 07, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article [...]
Axim® Biotechnologies Announces Positive Results From Stability And Dissolution Tests On Medchew Rx Showing Greater Than 90% Availability
07/08/2018
Results From Stability and Dissolution Testing on MedChew Rx® Controlled-Release Chewing Gum Show Over 90% Availability of Cannabinoid Molecules NEW YORK, Aug. 07, 2018 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. ( [...]
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
07/08/2018
FIT Biotech Oy Company release August 7, 2018 at 03:30 PM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on December 22, 2017 [...]
International Endeavors Corp. (IDVV) Subsidiary Applies for Funding under the Canadian CA$3 Billion Agricultural Program
07/08/2018
LAS VEGAS, Aug. 07, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- International Endeavors Corporation (OTC: IDVV) announces, as according to Forbes , that during July 2018, for the first time, the Canadian government made [...]
Novelion Therapeutics Reports Second Quarter 2018 Financial Results
07/08/2018
Following recent marketing approval in both generalized and partial lipodystrophy indications, European launch of MYALEPTA® has commenced VANCOUVER, British Columbia, Aug. 07, 2018 (GLOBE NEWSWIRE) -- Novelion [...]
Bellerophon Announces Results of Interim Analysis of Phase 3 INOvation-1 Study Evaluating INOpulse® for Treatment of Pulmonary Arterial Hypertension
07/08/2018
WARREN, N.J., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq:BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company, today announced that the Data Monitoring Committee [...]
Viveve Announces FDA Approval to Continue VIVEVE II Clinical Study
07/08/2018
Agency determines one-month safety data sufficient in first-stage and grants continued enrollment of up to 100 subjects in second stage of sexual function trial ENGLEWOOD, Colo., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Viveve [...]
Achroma Corp. Announces Global Survey Results of 226 People with Achromatopsia
07/08/2018
More than One-Third of People with Achromatopsia Were Misdiagnosed with Retinal or Cone Dystrophy Only 58% of Adults and 65% of Children with Achromatopsia Have Received Genetic Testing BUTLER, Pa., Aug. 07, 2018 (GLOBE [...]
Onconova Therapeutics, Inc. to Provide Corporate Update and Second Quarter 2018 Financial Results
07/08/2018
Company to Hold Conference Call and Webcast at 9:00 a.m. Eastern Time on Tuesday August 14, 2018 NEWTOWN, Pa., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3-stage [...]
Proteon Therapeutics Announces Second Quarter 2018 Financial Results
07/08/2018
WALTHAM, Mass., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with kidney and vascular [...]
Allena Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Business Update
07/08/2018
- Enrolling Global Phase 3 URIROX-1™ Trial; Plan to Initiate URIROX-2™ in 2H18 - - Treated First Patients in Phase 2 Basket Study of Reloxiliase (ALLN-177) for Primary Hyperoxaluria or Enteric Hyperoxaluria with [...]
Rexahn Issues Mid-Year Shareholder Letter to Review Recent Progress and Clinical Plans
07/08/2018
ROCKVILLE, Md., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American: RNN), a clinical stage biopharmaceutical company developing innovative, targeted therapeutics for the treatment of cancer, [...]

Pages